White House Chronicle

News Analysis With a Sense of Humor

  • Home
  • King’s Commentaries
  • Random Features
  • Photos
  • Public Speaker
  • WHC Episodes
  • About WHC
  • Carrying Stations
  • ME/CFS Alert
  • Contact Us

A Drug Goes Down in a Perfect Storm

February 7, 2013 by White House Chronicle Leave a Comment

A man you have never heard of is on a hunger strike in Reno, Nev., in a desperate petitioning of the government to do something to help bring a drug you have never heard of to some very sick people.
 
The man is Robert Miller, a former miner and bartender, who suffers from Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME). And the drug, which stimulates the immune system, is Ampligen.
 
Miller and the drug are at the heart of a perfect storm involving bureaucratic procedures, corporate ineptitude and a community of patients who have no Washington presence and therefore no strident voice.
 
Instead of a lobby, there are individuals — many of them very sick — who form a rag-tag pressure group, a small irregular army, who speak out on behalf of what is believed to be a million CFS sufferers in the United States.
 
The problems start with the disease itself, which like AIDS is a dramatic compromise of the immune system. It is hard to diagnose: There are no biological markers; there is no way to quickly identify it. Instead, it is what doctors call a waste-basket diagnosis: If it is not any of a list of ailments, then it must be CFS.
 
Some suffers report flu-like symptoms at the onset, building to a total collapse. Others simply collapse after exercise. Recovery is very rare — and only men. The disease undulates; good days and bad days, good years and bad years. In bad days and years, the victims are bedridden with intolerance of light and sound; restricted to bed and darkened rooms. Suicide is common, the suffering endless and severe.
 
I have talked to dozens of sufferers — the most heartrending are the teenage girls who are denied schooling, social life and the prospect of marriage by their ghastly affliction.
 
Enter Ampligen. It is an anti-viral compound developed in the 1970s and administered intravenously. Every patient is not helped by Ampligen, but many are restored to mobility after being bedridden. Robert Miller is one of these.
 
Last December, the Food and Drug Administration (FDA) heard from more than 700 patients praising Ampligen, with accounts of the choice it presented for them between functioning or being dependent on others.
 
Yet this month, the FDA rejected certification of the drug. The agency acknowledged the patient support, but castigated the company that makes Ampligen for incomplete data, a lack of scientific evidence of its efficacy and the way that it had handled the clinical trials.
 
There is a more-in-sorrow-than-in-anger tone in the FDA’s rejection of application for the drug by its maker Hemispherx Biopharma, Inc. of Philadelphia.
 
The FDA said: “As evidenced by the hundreds of letters, emails, and testimonies submitted to FDA, Myalgic Encephalomyelitis (ME) Chronic Fatigue Syndrome (CFS) is a devastating disease with a serious impact on quality of life. We are acutely aware of the seriousness of this disease, that no FDA approved treatments are available, and of the community's strong desire to see rintatolimod injection (Ampligen) approved.”
 
The bottom line is that the patients are to be denied a drug which helps some of them. Dr. Daniel Peterson of Simmaron Research in Incline Village, Nev., estimates that 70 percent of his patients are helped. Dr. Nancy Klimas of Nova Southeastern University in Florida, a dedicated supporter, puts the success rate lower.
 
For the patients, the dispute of methodology is irrelevant. What is relevant is that methodology has triumphed over humanity — and medicine.
 
Miller is continuing his hunger strike in the hope that the National Institutes of Health can be persuaded to conduct its own trials as, they can and do sometimes. But even if they do, it will be years before the FDA will rule again. — For the Hearst-New York Times Syndicate
 
 
Email, RSS Follow
Email

Filed Under: King's Commentaries Tagged With: Ampligen, Chronic Fatigue Syndrome, Dr. Daniel Peterson, Dr. Nancy Klimas, Food and Drug Administration, ME/CFS, myalgic encephalomyelitis, National Institutes of Health, Nova Southeastern University, Simmaron Research

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

White House Chronicle on Social

  • Facebook
  • Twitter
  • Vimeo
  • YouTube
Game-Changing Wind Turbines Harvest Underused Resource Close To The Ground

Game-Changing Wind Turbines Harvest Underused Resource Close To The Ground

Llewellyn King

Jimmy Dean, the country musician, actor and entrepreneur, famously said: “I can’t change the direction of the wind, but I can adjust my sails to always reach my destination.” A new wind turbine from a California startup, Wind Harvest, takes Dean’s maxim to heart and applies it to wind power generation. It goes after untapped, […]

Farewell to the U.S. as the World’s Top Science Nation

Llewellyn King

When I asked John Savage, the retired co-founder of the Department of Computer Science at Brown University, what the essential ingredient in research is, he responded with one word: “Passion.” It is passion that keeps scientists going, dead end after dead end, until there is a breakthrough. It is passion that keeps them at the […]

Europe Knows Russia and Is Deeply Afraid

Europe Knows Russia and Is Deeply Afraid

Llewellyn King

Europe is naked and afraid. That was the message at a recent meeting of the U.K. Section of the Association of European Journalists (AEJ), at which I was an invited speaker. It preceded a stark warning just over a week later from NATO Secretary General Mark Rutte, also speaking in London, who said the danger […]

A Commencement Address — Get Used to Rejections, We All Get Them Sometimes

A Commencement Address — Get Used to Rejections, We All Get Them Sometimes

Llewellyn King

It is school commencement season. So I am taking the liberty of sharing my column of May 10, 2024, which was first published by InsideSources, and later published by newspapers across the country.  As so many commencement addresses haven’t been delivered yet this year, I thought I would share what I would have said to […]

Copyright © 2025 · White House Chronicle Theme on Genesis Framework · WordPress · Log in